Miller Place, NY, United States of America

Robert Mauro

This inventor holds 4 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: University of Kansas, Silvergate Pharmaceuticals Inc., Silvergate Pharmacauticals, Inc.. Active years: 2013-2018.

USPTO Granted Patents = 4 

% Patents Active = 100.0

 

Average Co-Inventor Count = 8.0

ph-index = 4

Forward Citations = 70(Granted Patents)


Company Filing History:


Years Active: 2013-2018

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovations of Robert Mauro

Introduction

Robert Mauro is a notable inventor based in Miller Place, NY (US), recognized for his contributions to the field of pharmaceuticals. With a total of four patents to his name, Mauro has made significant strides in developing effective treatments for various medical conditions.

Latest Patents

Mauro's latest patents focus on enalapril compositions. These patents detail stable enalapril powder compositions designed for oral liquid formulation. Additionally, they outline methods for using these enalapril oral liquid formulations in treating diseases such as hypertension, heart failure, and asymptomatic left ventricular dysfunction.

Career Highlights

Throughout his career, Mauro has worked with esteemed organizations, including the University of Kansas Medical Center Research Institute and Silvergate Pharmaceuticals Inc. His work in these institutions has contributed to advancements in medical research and pharmaceutical development.

Collaborations

Mauro has collaborated with notable colleagues, including Lian G. Rajewski and Roger A. Rajewski. These partnerships have fostered innovation and enhanced the impact of his research.

Conclusion

Robert Mauro's contributions to pharmaceutical innovations, particularly in enalapril compositions, highlight his dedication to improving healthcare outcomes. His work continues to influence the field and offers promising solutions for patients with various medical conditions.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…